tiprankstipranks
Trending News
More News >
Biosyent Inc (TSE:RX)
:RX
Canadian Market

Biosyent (RX) Technical Analysis

Compare
49 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Biosyent Inc’s (RX) Moving Averages Convergence Divergence (MACD) indicator is 0.24, suggesting Biosyent Inc is a Buy.
Biosyent Inc’s (RX) 20-Day exponential moving average is 11.58, while Biosyent Inc’s (RX) share price is C$11.91, making it a Buy.
Biosyent Inc’s (RX) 50-Day exponential moving average is 11.24, while Biosyent Inc’s (RX) share price is C$11.91, making it a Buy.

Biosyent (RX) Pivot Points

Jun 12, 2025, 02:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.10
11.33
11.55
11.78
12.00
12.23
12.45
Fibonacci
11.33
11.50
11.60
11.78
11.95
12.05
12.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biosyent (RX) Moving Averages

Jun 12, 2025, 02:01 AM
Period
Simple
Exponential
MA5
11.79Buy
11.82Buy
MA10
11.75Buy
11.75Buy
MA20
11.60Buy
11.58Buy
MA50
10.97Buy
11.24Buy
MA100
10.98Buy
11.06Buy
MA200
10.98Buy
10.84Buy
Biosyent Inc’s (RX) 10-Day exponential moving average is 11.75, while Biosyent Inc’s (RX) share price is C$11.91, making it a Buy.
Biosyent Inc’s (RX) 100-Day exponential moving average is 11.06, while Biosyent Inc’s (RX) share price is C$11.91, making it a Buy.
Biosyent Inc’s (RX) stock price is C$11.91 and Biosyent Inc’s (RX) 50-day simple moving average is 10.97, creating a Buy signal.
Biosyent Inc’s (RX) stock price is C$11.91 and Biosyent Inc’s (RX) 100-day simple moving average is 10.98, creating a Buy signal.
Biosyent Inc’s (RX) stock price is C$11.91 and Biosyent Inc’s (RX) 200-day simple moving average is 10.98, creating a Buy signal.

Biosyent (RX) Technical Indicators

Jun 12, 2025, 02:01 AM
Name
Value
Implied Action
RSI (14)
62.66
Neutral
STOCH (9,6)
73.33
Neutral
STOCHRSI (14)
82.35
Sell
MACD (12,26)
0.24
Buy
ADX (14)
14.40
Buy
Williams %R
-13.24
Sell
CCI (14)
56.87
Neutral
ATR (14)
0.25
-
Ultimate Oscillator
58.39
Neutral
ROC
2.23
Buy
Biosyent Inc’s (RX) Relative Strength Index (RSI) is 62.66, creating a Neutral signal.
Biosyent Inc’s (RX) Trend Strength Indicator (ADX) is 14.40, creating a Buy signal.
Biosyent Inc’s (RX) Commodity Channel Index (CCI) is 56.87, creating a Neutral signal.
Biosyent Inc’s (RX) Price Rate of Change (ROC) is 2.23, creating a Buy signal.

FAQ

Is RX a Buy, Hold, or Sell?
Based on RX’s technical indicators, RX is a Strong Buy.
    What is RX’s RSI (14)?
    RX’s RSI (14) is 62.66, which suggests RX is a Neutral.
      What is RX’s MACD?
      RX’s MACD is 0.24, which suggests RX is a Buy.
        What is RX’s 5-day moving average?
        RX’s 5-day moving average is 11.79, which suggests RX is a Buy.
          What is RX’s 20-day moving average?
          RX 20-day moving average is 11.60, which suggests RX is a Buy.
            What is RX’s 50-day moving average?
            RX’s 50-day moving average is 10.97, which suggests RX is a Buy.
              What is RX’s 200-day moving average?
              RX’s 200-day moving average is 10.98, which suggests RX is a Buy.
                What is RX’s Williams % R (14)?
                RX’s Williams % R (14) is -13.24, which suggests RX is a Sell.
                  What is RX’s CCI (14)?
                  RX’s CCI (14) is 56.87, which suggests RX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis